Stocktoria
OMEROS CORP OMER
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-10-08
OMEROS CORP statistics & valuation
Market cap$627.5M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -1.0% | -56.6% | -31.1% | 8.0% | 46.3% |
| Return on equity | 2.8% | 85.9% | 471.6% | 55.3% | 816.8% |
| Debt / equity | -0.73× | -0.90× | -8.53× | 3.68× | 13.18× |
| Current ratio | 2.76 | 1.69 | 4.09 | 3.25 | 4.79 |
Source: SEC EDGAR filings · CIK 0001285819 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.